Exenatide Increases Hypothalamic Connectivity in Obese Men: First Evidence of 
Central appetite modulating Effects in fMRI Analyzed With Eigenvector 
Centrality Mapping

Schloegl, H; Villringer, A; Kabisch, S; Horstmann, A; Lepsien, J; Mueller, K; Kratzsch, J; Busse, FP; Pleger, B; Stumvoll, M; Lohmann, G

doi:10.1038/oby.2010.158

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Poster

Exenatide Increases Hypothalamic Connectivity in Obese Men: First Evidence of Central appetite modulating Effects in fMRI Analyzed With Eigenvector Centrality Mapping

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

https://onlinelibrary.wiley.com/doi/epdf/10.1038/oby.2010.158
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schloegl, H., Villringer, A., Kabisch, S., Horstmann, A., Lepsien, J., Mueller, K., et al. (2010). Exenatide Increases Hypothalamic Connectivity in Obese Men: First Evidence of Central appetite modulating Effects in fMRI Analyzed With Eigenvector Centrality Mapping. Poster presented at 28th Annual Scientific Meeting of the Obesity Society (OBESITY 2010), San Diego, CA, USA.

Cite as: https://hdl.handle.net/21.11116/0000-0002-9936-5

Abstract

Exenatide is a glucagon-like peptide-1 (GLP-1) analog, used in clinical practice for treatment of type-2-diabetes. It increases energy intake and reduces body weight in long-term treatment in humans, but the underlying
physiological mechanisms are still unclear. To investigate its central nervous effects we performed functional magnetic resonance imaging (fMRI) in 20 male obese (body mass index 28.4 - 42.8 kg/m², mean 34.6 kg/m²; age 20 - 47 years, mean 28 years) while intravenously administrating exenatide. Infusion rate was 0.12 pmol/kg/min., total duration of infusion was 2.5 hours, the study design was cross-over, placebo controlled, double-blind and randomized. Inside the scanner subjects rated pictures of food regarding their tastiness. We used a recently published parameter-free method called ‘eigenvector centrality mapping’ (ECM) for assessing functional con-
nectivity in each voxel (Lohmann et al. 2010). ECM attributes a centrality value to each voxel reflecting its degree of connectedness. Results showed a statistically significant global maximum for higher centrality (which
suggests a higher connectivity) in hypothalamus in the exenatide condition compared to placebo. The hypothalamus is a key region for the control of energy homeostasis, where from animal data it is known that GLP-1 receptors are present and involved in regulation of energy uptake. Our results demonstrate that peripherally administered exenatide mediates centrality in food-related networks. This shows for the first time a modulation of central
networks regulating energy homeostasis after exenatide infusion and suggests a central nervous mechanism for the reduction of energy intake under influence of exenatide.